14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:OMED
Delisted

OncoMed Pharmaceuticals Stock Insider Trading

$0.89
+0 (+0%)
At Close: Sep 17, 2019
Date Action Amount Person Type
Apr 23, 2019 Sell 39 488 Hager Alicia J. Common Stock
Apr 23, 2019 Sell 121 020 Root Jonathan D Common Stock
Apr 23, 2019 Sell 142 534 Lewicki John A. Common Stock
Apr 23, 2019 Sell 18 940 Pakianathan Deepika Common Stock
Dec 31, 2018 Buy 0 Lewicki John A.
Dec 24, 2018 Sell 11 117 Gurney Austin Common Stock
Oct 10, 2018 Sell 1 156 Gurney Austin Common Stock
Oct 10, 2018 Sell 1 156 Hager Alicia J. Common Stock
Oct 10, 2018 Sell 1 156 Lewicki John A. Common Stock
Oct 09, 2018 Sell 1 686 Gurney Austin Common Stock
Oct 09, 2018 Sell 2 296 Lewicki John A. Common Stock
Oct 09, 2018 Sell 1 686 Hager Alicia J. Common Stock
Jun 22, 2018 Buy 15 000 Pakianathan Deepika Stock Option (Right to Buy)
Jun 22, 2018 Buy 15 000 Root Jonathan D Stock Option (Right to Buy)
Jun 22, 2018 Buy 15 000 Winningham Rick E Stock Option (Right to Buy)
Apr 24, 2018 Sell 4 557 Lewicki John A. Common Stock
Apr 24, 2018 Sell 4 051 Gurney Austin Common Stock
Apr 24, 2018 Sell 4 051 Hager Alicia J. Common Stock
Mar 16, 2018 Buy 125 000 Lewicki John A. Stock Option (Right to Buy)
Feb 21, 2018 Buy 125 000 Lewicki John A. Stock Option (Right to Buy)
Jan 04, 2018 Buy 100 000 Patel Sunil Stock Option (Right to Buy)
Jan 04, 2018 Buy 100 000 Lewicki John A. Stock Option (Right to Buy)
Jan 04, 2018 Buy 70 000 Gurney Austin Stock Option (Right to Buy)
Jan 04, 2018 Buy 70 000 Hager Alicia J. Stock Option (Right to Buy)
Dec 31, 2017 Buy 0 Lewicki John A.
Oct 10, 2017 Sell 46 Patel Sunil Common Stock
Oct 10, 2017 Sell 1 202 Patel Sunil Common Stock
Oct 10, 2017 Sell 52 Hastings Paul J Common Stock
Oct 10, 2017 Sell 1 346 Hastings Paul J Common Stock
Oct 10, 2017 Sell 46 Lewicki John A. Common Stock
Oct 10, 2017 Sell 1 202 Lewicki John A. Common Stock
Oct 10, 2017 Sell 46 Gurney Austin Common Stock
Oct 10, 2017 Sell 1 202 Gurney Austin Common Stock
Oct 10, 2017 Sell 46 Hager Alicia J. Common Stock
Oct 10, 2017 Sell 1 202 Hager Alicia J. Common Stock
Oct 07, 2017 Buy 25 000 Patel Sunil Common Stock
Oct 07, 2017 Buy 50 000 Patel Sunil Stock Option (Right to Buy)
Oct 07, 2017 Buy 25 000 Lewicki John A. Common Stock
Oct 07, 2017 Buy 50 000 Lewicki John A. Stock Option (Right to Buy)
Oct 07, 2017 Buy 18 334 Hager Alicia J. Common Stock
Oct 07, 2017 Buy 36 666 Hager Alicia J. Stock Option (Right to Buy)
Oct 07, 2017 Buy 18 334 Gurney Austin Common Stock
Oct 07, 2017 Buy 36 666 Gurney Austin Stock Option (Right to Buy)
Jun 01, 2017 Buy 15 000 Pakianathan Deepika Stock Option (Right to Buy)
Jun 01, 2017 Buy 15 000 Lasky Laurence Stock Option (Right to Buy)
Jun 01, 2017 Buy 15 000 Root Jonathan D Stock Option (Right to Buy)
Jun 01, 2017 Buy 15 000 Winningham Rick E Stock Option (Right to Buy)
May 26, 2017 Sell 3 222 Root Jonathan D Common Stock
May 24, 2017 Sell 2 853 Root Jonathan D Common Stock
May 24, 2017 Sell 1 447 Root Jonathan D Common Stock
May 19, 2017 Sell 4 968 Root Jonathan D Common Stock
May 19, 2017 Sell 2 519 Root Jonathan D Common Stock
May 16, 2017 Sell 4 579 Root Jonathan D Common Stock
May 16, 2017 Sell 2 321 Root Jonathan D Common Stock
May 11, 2017 Buy 55 929 Root Jonathan D Common Stock
May 11, 2017 Sell 19 215 Root Jonathan D Common Stock
Apr 24, 2017 Buy 135 000 Hastings Paul J Stock Option (Right to Buy)
Apr 24, 2017 Buy 45 000 Hastings Paul J Common Stock
Apr 23, 2017 Buy 60 000 Patel Sunil Stock Option (Right to Buy)
Apr 23, 2017 Buy 20 000 Patel Sunil Common Stock
Apr 23, 2017 Buy 67 500 Lewicki John A. Stock Option (Right to Buy)
Apr 23, 2017 Buy 22 500 Lewicki John A. Common Stock
Apr 23, 2017 Buy 20 000 Gurney Austin Common Stock
Apr 23, 2017 Buy 60 000 Gurney Austin Stock Option (Right to Buy)
Apr 23, 2017 Buy 60 000 Hager Alicia J. Stock Option (Right to Buy)
Apr 23, 2017 Buy 20 000 Hager Alicia J. Common Stock
Apr 04, 2017 Sell 43 Lewicki John A. Common Stock
Apr 04, 2017 Sell 5 711 Lewicki John A. Common Stock
Apr 04, 2017 Sell 43 Gurney Austin Common Stock
Apr 04, 2017 Sell 5 711 Gurney Austin Common Stock
Apr 04, 2017 Sell 43 Patel Sunil Common Stock
Apr 04, 2017 Sell 5 711 Patel Sunil Common Stock
Apr 04, 2017 Sell 32 Hager Alicia J. Common Stock
Apr 04, 2017 Sell 4 284 Hager Alicia J. Common Stock
Apr 04, 2017 Sell 48 Hastings Paul J Common Stock
Apr 04, 2017 Sell 6 425 Hastings Paul J Common Stock
Mar 15, 2017 Buy 6 652 Hager Alicia J. Common Stock
Mar 15, 2017 Sell 6 652 Hager Alicia J. Common Stock
Mar 15, 2017 Sell 6 652 Hager Alicia J. Stock Option (Right to Buy)
Jan 06, 2017 Buy 21 369 Hastings Paul J Common Stock
Jan 06, 2017 Sell 21 369 Hastings Paul J Common Stock
Jan 06, 2017 Sell 21 369 Hastings Paul J Stock Option (Right to Buy)
Jan 05, 2017 Sell 21 369 Hastings Paul J Common Stock
Jan 05, 2017 Sell 21 369 Hastings Paul J Stock Option (Right to Buy)
Jan 03, 2017 Buy 65 000 Lewicki John A. Stock Option (Right to Buy)
Jan 03, 2017 Buy 9 175 Lewicki John A. Common Stock
Jan 03, 2017 Sell 9 175 Lewicki John A. Common Stock
Jan 03, 2017 Sell 9 175 Lewicki John A. Stock Option (Right to Buy)
Jan 03, 2017 Buy 55 000 Hager Alicia J. Stock Option (Right to Buy)
Jan 03, 2017 Buy 176 000 Hastings Paul J Stock Option (Right to Buy)
Jan 03, 2017 Buy 65 000 Patel Sunil Stock Option (Right to Buy)
Jan 03, 2017 Buy 55 000 Gurney Austin Stock Option (Right to Buy)
Oct 09, 2016 Buy 12 500 Lewicki John A. Common Stock
Oct 09, 2016 Buy 14 000 Hastings Paul J Common Stock
Oct 09, 2016 Buy 12 500 Gurney Austin Common Stock
Oct 09, 2016 Buy 12 500 Dupont Jakob Common Stock
Oct 09, 2016 Buy 12 500 Patel Sunil Common Stock
Oct 09, 2016 Buy 12 500 Hager Alicia J. Common Stock
Jun 22, 2016 Buy 15 000 Winningham Rick E Stock Option (Right to Buy)
Jun 22, 2016 Buy 15 000 Root Jonathan D Stock Option (Right to Buy)
INSIDER POWER
0
Last 100 transactions
Buy: 2 080 625 | Sell: 547 589 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 2 080 625 and sold 547 589 OMED shares in the last 100 trades.

Click to get the best stock tips daily for free!

About OncoMed Pharmaceuticals

OncoMed Pharmaceuticals, Inc., a clinical development-stage biopharmaceutical company, discovers and develops novel anti-cancer stem cell (CSC) and immuno-oncology therapeutics. The company’s product candidates and preclinical programs include demcizumab (anti-DLL4, OMP-21M18), a humanized monoclonal antibody, which is in two Phase II clinical trials for non-small cell lung cancer and pancreatic cancer patients; tarextumab (anti-Notch2/3, OMP-59... OMED Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT